[go: up one dir, main page]

HK1223416A1 - 用於诊断肠易激惹综合征的方法 - Google Patents

用於诊断肠易激惹综合征的方法 Download PDF

Info

Publication number
HK1223416A1
HK1223416A1 HK16111563.6A HK16111563A HK1223416A1 HK 1223416 A1 HK1223416 A1 HK 1223416A1 HK 16111563 A HK16111563 A HK 16111563A HK 1223416 A1 HK1223416 A1 HK 1223416A1
Authority
HK
Hong Kong
Prior art keywords
score
antibody
ibs
marker
sample
Prior art date
Application number
HK16111563.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1223416B (zh
Inventor
Stefan Westin
Fabiyola SELVARAJ
Fred Princen
Sharat Singh
Original Assignee
Société des Produits Nestlé S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société des Produits Nestlé S.A. filed Critical Société des Produits Nestlé S.A.
Publication of HK1223416A1 publication Critical patent/HK1223416A1/zh
Publication of HK1223416B publication Critical patent/HK1223416B/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • G01N33/942Serotonin, i.e. 5-hydroxy-tryptamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
HK16111563.6A 2013-05-24 2014-05-22 用於診斷腸易激惹綜合征的方法 HK1223416B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361827506P 2013-05-24 2013-05-24
US201361827506P 2013-05-24
PCT/IB2014/061636 WO2014188378A1 (en) 2013-05-24 2014-05-22 Pathway specific markers for diagnosing irritable bowel syndrome

Publications (2)

Publication Number Publication Date
HK1223416A1 true HK1223416A1 (zh) 2017-07-28
HK1223416B HK1223416B (zh) 2020-07-17

Family

ID=

Also Published As

Publication number Publication date
AU2014269960B2 (en) 2018-05-10
JP2016520199A (ja) 2016-07-11
IL242597B (en) 2019-02-28
CN105579852A (zh) 2016-05-11
BR112015029318A2 (pt) 2017-07-25
US20180321259A1 (en) 2018-11-08
AU2018214104A1 (en) 2018-08-30
KR20160013163A (ko) 2016-02-03
EP3004892A1 (en) 2016-04-13
US20180136233A1 (en) 2018-05-17
JP2019194600A (ja) 2019-11-07
CN105392780A (zh) 2016-03-09
CA2913108A1 (en) 2014-11-27
HK1223361A1 (zh) 2017-07-28
US20170307637A1 (en) 2017-10-26
AU2014269960A1 (en) 2015-11-26
WO2014188378A1 (en) 2014-11-27
RU2015155552A (ru) 2017-06-27
BR112015029320A2 (pt) 2017-07-25
WO2014188377A2 (en) 2014-11-27
BR112015029320A8 (pt) 2023-01-03
US9739786B2 (en) 2017-08-22
US10036759B2 (en) 2018-07-31
CA2912993A1 (en) 2014-11-27
RU2015155590A (ru) 2017-06-29
US9891235B2 (en) 2018-02-13
WO2014188377A3 (en) 2015-03-05
EP3004068A2 (en) 2016-04-13
US10338083B2 (en) 2019-07-02
US20160130279A1 (en) 2016-05-12
IL242595B (en) 2019-01-31
US20160139148A1 (en) 2016-05-19
JP2019151637A (ja) 2019-09-12
SG11201509371XA (en) 2015-12-30
JP2016521683A (ja) 2016-07-25
EP3004892B1 (en) 2018-10-10
CN105579852B (zh) 2017-12-01
SG11201509370UA (en) 2015-12-30
KR20160010621A (ko) 2016-01-27
MX367046B (es) 2019-08-02
AU2014269961A1 (en) 2015-11-26

Similar Documents

Publication Publication Date Title
US10338083B2 (en) Pathway specific markers for diagnosing irritable bowel syndrome
JP6634544B2 (ja) 過敏性腸症候群の診断方法
JP5571951B2 (ja) 試料が過敏性腸症候群と関連するか否かを決定する分類方法
AU2012254150B2 (en) Assays for detecting autoantibodies to anti-TNFalpha drugs
US20120315630A1 (en) Methods for diagnosing irritable bowel syndrome
EP2710383B1 (en) Performance of a biomarker panel for irritable bowel syndrome
HK1223416B (zh) 用於診斷腸易激惹綜合征的方法
Ajamian Investigating Markers of Intestinal Barrier Dysfunction in Gastrointestinal Diseases
NZ614170B2 (en) Assays for detecting autoantibodies to anti-tnf? drugs

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240527